Sanai Health Industry Group Co. Ltd. is an investment holding company, which through its subsidiaries, engages in developing, manufacturing, marketing, and sales of pharmaceutical products. It operates through the following segments: Pharmaceutical Products, Finance Leasing, Other General Trading, and Genetic Testing and Molecular Diagnostic Services. The Pharmaceutical Products segment engages in development, manufacturing, marketing and sales of pharmaceutical products and sales of health care products. The Finance Leasing segment engages in provision of finance leasing services. The Other General Trading segment engages in trading of goods other than pharmaceutical products. The Genetic Testing and Molecular Diagnostic Services segment engages in provision of genetic testing and molecular diagnostic services. The firm focuses on therapeutic drugs for respiratory, cardiovascular, and gastrointestinal diseases, as well as parenteral nutrition, antibiotics, antiviral, and antifungal products. The company was founded on March 21, 2006 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company